Contraindications * Hypersensitivity to<unk>  * Pre-existing breast cancer or other prolactin-dependent tumors * Phaeochromocytoma * Intoxication with other centrally-active drugs * Concomitant use of levodopa * Acute porphyria * Comatose state or CNS depression * Bone-marrow suppression Cautions * Pre-existing Parkinson's disease * Patients under 18 years of age (insufficient clinical data) * Pre-existing severe heart disease/bradycardia, or hypokalemia (predisposing to long QT syndrome and severe arrhythmias) * Patients with pre-existing epilepsy. Anticonvulsant therapy should be maintained * Lithium use — increased risk of neurological side effects of both drugs Pregnancy and lactation * Pregnancy: Animal studies did not reveal any embryotoxicity or fetotoxicity, nor did limited human experience. Due to insufficient human data, pregnant women should be treated with<unk>  only if strictly indicated. Additionally, the newborns of treated women should be monitored, because isolated cases of extrapyramidal side effects have been reported. * Lactation:<unk>  is found in the milk of lactating women. Since the consequences are unclear, women should not breastfeed during treatment.
Sulpiride
Buspirone
Dapoxetine
Bupropion
Vortioxetine
Electroconvulsive therapy
Atomoxetine
Edivoxetine